This federal contract award was issued by the Defense Logistics Agency (DLA) to the pharmaceutical distributor Amerisourcebergen Drug Corp. The $1,805.73 firm-fixed-price delivery order covers the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product used in the treatment and management of various medical conditions. The contract has an ultimate completion date of December 6, 2024.
Amerisourcebergen Drug Corp is a major healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Amerisourcebergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
This contract award was not designated with a set-aside requirement, indicating open competition. The DLA is the primary funding agency for this contract, which aligns with the agency's role in supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries through streamlined contracting mechanisms.
Generated 3/6/25, 9:50 AM